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The effect of the flavonoid and saponin fractions from the leaves and root bark of Zizyphus lotus (200 mg/kg) was evaluated on carrageenan-
induced paw edema in rats and on acetic acid-induced algesia in mice. In addition, two methanolic extracts from the plant (1 mg/ear) were tested
on oxazolone-induced contact-delayed hypersensitivity (DTH) in mice. The effect of the different fractions was also evaluated in vitro on the
nitrite production induced by lipopolysaccharide (LPS) in RAW 264.7 macrophages. The results showed that both the flavonoid and saponin
fractions significantly inhibited paw edema, algesia, and nitrite production without affecting cell viability. Furthermore, the methanolic extracts of
the leaves and root bark of Z. lotus were found to significantly inhibit the DTH induced by oxazolone, with the extract obtained from root bark
being more active than that obtained from leaves.
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Many plants used in traditional medicine have the potential
to provide pharmacologically active natural products. For
example, several recent pharmacological studies (Nunes et al.,
1987; Adzu et al., 2001; Borgi et al., 2007) have focused on the
various species of Zizyphus (Rhamnaceae), including Zizyphus
lotus, a species commonly known as ‘sedra’ in Tunisia, where it
is used in traditional medicine as a pectoral demulcent to treat
throat and broncho-pulmonic irritations (Le-Floc'h, 1983). In a
previous study, we reported on the anti-inflammatory and
analgesic activities of Z. lotus root bark (Borgi et al., 2007). In
the present study, we have gone on to investigate the effects of
the flavonoid and saponin fractions of the root bark and leaves
of Z. lotus on both carrageenan-induced paw edema in rats and
the algesia induced in mice by the intraperitoneal administration⁎ Corresponding author. Tel.: +216 73 461000; fax: +216 73 461830.
E-mail address: wahida_b2002@yahoo.fr (W. Borgi).
0254-6299/$ - see front matter © 2008 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2008.01.009of acetic acid. We have also examined the effects of the extracts
on nitrite production in RAW 264.7 macrophages. In addition,
methanolic extracts from the root bark and leaves were tested on
oxazolone-induced contact-delayed type hypersensitivity
(DTH) in mice. Finally, the cytotoxicity of Z. lotus fractions
on different cells was evaluated.
2. Materials and methods
2.1. Reagents
Carrageenan (BDH Chemicals Ltd Poole England), and
acetylsalicylic acid (AAS) were from Adwya Laboratory,
Tunisia. RAW 264.7 macrophages, lipopolysaccharide (LPS)
from Escherichia coli 0111:B4 (Sigma), Nω-nitro-L-arginine
methyl ester (L-NAME) and DMEM medium all from
Invitrogen, Langley, OK, USA. 96-well microplates, oxazolone,
dimethyl sulfoxide (DMSO), 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT), Griess reagent and acetic
acid were purchased from Sigma.ts reserved.
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Z. lotus (L.) Lam. was collected in Cherahil-Monastir, Tunisia,
in 2005 and identified in the Botanic laboratory of the Faculty of
Pharmacy in Monastir. A voucher specimen (No. 0269) has been
deposited in the Herbarium of the Department of Pharmacognosy,
Faculty of Pharmacy, in Monastir, Tunisia.
2.3. Preparation of extracts
The root bark (RB) and leaves (L) were dried, coarsely
powdered, and exhaustively extracted in a Soxhlet apparatus
with methanol for 8 h to yield the methanolic extract (ME); ME-
RB: 25.27% and ME-L: 15.28%. In order to obtain total oligo-
mers flavonoids (TOF), the powdered root bark and leaves were
macerated separately for 24 h in a mixture of acetone/water
(2:1). Each extract was then filtered and the acetone was eva-
porated under low pressure. Tannins were removed from the
aqueous phase through precipitation with NaCl for 24 h at 5 °C
and the supernatant was then extracted with ethyl acetate, con-
centrated, and precipitated with an excess of chloroform. The
precipitate containing TOF was separated by means of filtration
(Paris and Moyse, 1976a,b,c). The yield of TOF-RB and TOF-L
fractions was 0.12% and 0.13%, respectively. The presence of
flavonoids was verified by the reaction of ‘cyanidine’ in the
presence of hydrochloric acid and of magnesium. After release
of hydrogen, a coloring of orange with the red purple indicates
the presence of the flavonoids. The revelation of the spots cor-
responding to the flavonoids on the plates of thin layer chro-
matography (TLC) is done by pulverization using a solution of
AlCl3 in methanol 2%. The plates of TLC are then observed
under UVwith 366 nm: the spots corresponding to the flavonoids
have a yellow fluorescence at intense yellow (Paris and Moyse,
1976a,b,c).
The saponin fraction (S) was obtained as follows: powdered
root bark and leaves were macerated separately in petroleum
ether. After 24 h, each defatted plant material was macerated in
MeOH for another 24 h and then the filtrate was concentrated
under low pressure. Ethyl ether was added to the methanolic
extract and kept at −5 °C for 24 h. A precipitate was obtained
under low pressure and was separated by means of filtration
(Boiteau et al., 1964). The yield of S-RB and S-L fractions was
2.19% and 0.34%, respectively. The presence of saponins was
verified as follow: after dissolution of the active ingredients in
hot water, the tubes containing the solutions are agitated during
15 s (2 agitations a second). The development of persistent foam
which lasts more than 15 min indicates the presence of the
saponins (Boiteau et al., 1964).
2.4. Animals
For studying the anti-inflammatory and analgesic activities,
adult Wistar rats (150–200 g) and Swiss albino mice (18–22 g)
were obtained from the Pasteur Institute (Tunis, Tunisia). For
experiments on oxazolone-induced hypersensitivity in mice,
animals were obtained from Harlan InterFauna Ibérica (Barce-
lona, Spain). All animals were fed a standard diet ad libitum andallowed free access to drinking water. Animals fasted overnight
before any experiments, all of which were conducted in accor-
dance with the guidelines established by the European Union on
Animal Care (CEE Council 86/609). Housing conditions and all
in vivo experiments were approved and followed by the Insti-
tutional Ethics Committee of the Faculty of Pharmacy (Univer-
sity of Valencia, Spain).
2.5. Anti-inflammatory activity
2.5.1. Carrageenan-induced rat paw edema
Wistar rats were divided into groups of six animals each.
Edema was induced by injecting 0.05 ml of 1% carrageenan
subcutaneously into the sub-plantar region of the left hind paw
(Winter et al., 1962). Flavonoid (TOF) and saponin (S) fractions
of the root bark (RB) and leaves (L) of Z. lotus (200 mg/kg) were
administered intraperitoneally (i.p.). The reference group received
acetylsalicylic acid (ASA, 300 mg/kg, i.p.) and the control group
received a solution of 9‰ NaCl (2.5 ml/kg, i.p). All drugs were
administrated 15 min before the injection of carrageenan. The
hind paw volume was measured with a plethysmometer (model
7150, Ugo Basile, Comerio, Italy) at 0 h (before carrageenan
injection) and then again at 0.5, 1, 2, 3, 4, 6, and 24 h.
2.5.2. Oxazolone-induced delayed type hypersensitivity in mice
In accordance with the method previously described byYoung
andDeYoung (1989), femalemice (n=6)were sensitized through
topical application to the shaved ventral abdomen of 150 µl of a
3% (w/v) solution of oxazolone in acetone on day 1. Challenge
was performed on day 6 by applying 10 µl of 1% oxazolone to
the inner and outer surfaces of both ears. Root bark (ME-RB) and
leaf (ME-L) methanolic extracts (1 mg/ear) and dexamethasone
(0.025 mg/ear) were applied topically (10 µl) to the inner and
outer surface of right ear on days 6, 7, and 8 after challenge. The
thickness of each ear was measured with a micrometer (Mitutoyo
Series 293, Kawasaki, Japan) on days 7, 8, and 9 after challenge
just before drug application. The edema was calculated for each
ear as the difference in thickness before treatment and 24, 48, and
72 h after challenge. The activity was expressed as the inhibition
percentage of ear thickness with reference to the control group.
2.6. Cytotoxicity assay
The cytotoxicity of Z. lotus extracts was determined with
the aid of the colorimetric assay (Mosmann, 1983). Cells were
exposed to the extracts (50–1000 µg/ml) in a microplate for
30 min (rat peritoneal neutrophils) or 1 day (RAW 264.7
macrophages) and then 100 µl/well of a 5 mg/ml solution of 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT) was added. The plates were then incubated at 37 °C
until blue deposits were visible. The coloured metabolite was
dissolved in dimethyl sulfoxide (100 µl per well). Absorbance
was measured at 490 nm with a Labsystems Muliskan MCC/
340 plate reader (Helsinki, Finland). Results are expressed as
absolute absorbance readings with a decrease indicating a
diminution in cell viability. Controls received vehicle only and
correspond to 100% viability.
Table 1





Paw edema volume mean (10−2 ml)±s.e.m. (%I)
0.5 h 1 h 2 h 3 h 4 h 6 h 24 h
Control 1 22.37±1.41 38.87±3.29 68.00±6.31 96.75±8.87 106.25±10.04 114.75±11.43 77.25±6.77
ASA 300 12.25±0.62*** 14.50±1.55*** 17.25±1.31*** 27.25±4.26*** 31.00±3.18*** 42.50±3.77** 46.25±6.86*
(45) (63) (75) (72) (71) (63) (40)
Control 2 28.25±2.50 63.25±4.99 112.50±9.87 157.25±12.19 170.50±14.14 182.00±14.21 110.00±13.70
TOF-RB 200 15.66±6.67** 24.33±3.84*** 33.00±3.78*** 39.00±3.60*** 44.00±2.30*** 57.33±6.17*** 45.33±5.78**
(45) (62) (71) (75) (74) (68) (59)
TOF-L 200 23.66±2.90ns 36.33±4.84* 69.33±5.48* 84.00±10.69** 91.66±13.38* 112.33±17.36* 72.66±7.31ns
(16) (43) (38) (47) (46) (38) (34)
Control 3 24.00±2.12 35.20±5.32 66.60±1252 120.20±13.76 151.80±18.21 147.60±11.96 92.80±3.80
S-RB 200 11.66±1.33** 11.00±2.00** 10.66±0.88** 12.00±1.15** 11.33±0.33** 15.66±2.33** 21.66±5.92**
(51) (69) (84) (90) (93) (89) (77)
S-L 200 17.33±0.33ns 22.00±1.00ns 24.33±1.33* 42.33±1.66** 57.33±8.00** 56.66±9.20** 51.66±11.20**
(28) (38) (64) (65) (62) (62) (44)
Data are expressed as mean±s.e.m. (n=6), *Pb0.05, **Pb0.01, ***Pb0.001, ns: not significant vs. control. Statistical analysis was performed with Student's t-test.
%I: percentage inhibition, TOF-RB: total oligomers flavonoids of root bark, TOF-L: total oligomers flavonoids of leaves, S-RB: saponins of root bark, S-L: saponins
of leaves, ASA: acetylsalicylic acid.
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RAW 264.7 macrophages were cultured in a DMEMmedium
containing 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml
streptomycin and 10% foetal bovine serum. Cells were removed
from the tissue culture flask with a cell scraper and resuspended
until a final relation of 1×106 cells/ml was reached. The cells
were then co-incubated in a 96-well culture plate (200 µl) with
1 µg/ml of lipopolysaccharide (LPS) at 37 °C for 24 h in the
presence of extracts (50 and 100 µg/ml), DMSO (control), orNω-
nitro-L-arginine methyl ester (L-NAME) as a reference drug. The
supernatants were used directly to measure nitrite production by
first mixing them with Griess reagent and then reading the ab-
sorbance at 570 nm in a microplate reader (Bas et al., 2007).
Nitrite production was assessed as the index of NOS activity.
2.8. Antinociceptive activity
Swiss mice were selected 1 day prior to the assay and were
divided into different groups of six animals each. The control
group was treated with 10 mg/kg, i.p. of 9‰ NaCl. The positive
control (reference) group received acetylsalicylic acid (ASA,
200mg/kg, i.p.) while the remaining groups were given TOF-RB,
TOF-L, S-RB, and S-L of Z. lotus (200 mg/kg, i.p.). Fifteen
minutes later, 1% acetic acid (10 ml/kg. i.p.) was injected into
each animal and the amount of writhing during the followingTable 2
Inhibitory effects of Z. lotus extracts on oxazolone-induced contact-delayed hyperse
Treatment ΔT (µm)





Z. lotus extracts dose=1 mg/ear×3 applications, Dexamethasone 0.05 mg/ear,ΔT=in
s.e.m. (n=6), *Pb0.05, **Pb0.01, ***Pb0.001, ns: not significant vs. control. Stati
leaves; ME-RB: methanolic extract of root bark).30 min was quantified. A significant reduction in writhing as
compared to the control group was considered to be an anti-
nociceptive response (Koster et al., 1959).
2.9. Data analysis
Data are presented as the mean±standard error (s.e.m.). Statis-
tical analysis was performed using Student's t-test. The signifi-
cance of difference was considered to include values of Pb0.05.
3. Results and discussion
In a previous study (Borgi et al., 2007),we reported on the anti-
inflammatory and analgesic properties of the aqueous and metha-
nolic extracts (200 mg/kg, i.p.) of the root bark of Z. lotus. The
results showed that the polar extracts (aqueous and methanolic
extracts) were more active than the chloroformic and the ethyl
acetate extracts. We also verified the presence of flavonoids
and saponins in these extracts, so we direct our research towards
the effect of these fractions and their participation in the anti-
inflammatory activity. The results obtained in this study indicate
that these fractions at the dose of 200 mg/kg administered
intraperitoneally present a significant effect against carrageenan-
induced inflammation and their effect was more important.
In carrageenan-induced rat paw edema (Table 1), the extracts
TOF-RB, TOF-L, S-RB, and S-L (all at 200mg/kg, i.p.) producednsitivity ear edema in mice
%I
72 h 24 h 48 h 72 h
148.13±17.90 – – –
95.69±12.26* 48 22 35
78.90±7.89** 58 36 47
28.52±15.38*** 75 69 81
crease in ear thickness, %I= inhibition percentage. Data are expressed as mean±
stical analysis was performed with Student's t-test. (ME-L: methanolic extract of
Table 4







Control 1 – 100.84±5.64 –
ASA 200 36.95±6.27*** 63
Control 2 – 102.40±6.71 –
TOF-RB 200 19.00±0.00*** 81
TOF-L 200 74.33±9.05* 27
S-RB 200 54.33±16.41* 47
S-L 200 12.00±2.68*** 88
Values are expressed as mean±s.e.m. *Pb0.05, ***Pb0.001. Statistical ana-
lysis was performed with Student's t-test. (TOF-RB: total oligomers flavonoids
of root bark, TOF-L: total oligomers flavonoids of leaves, S-RB: saponins of
root bark, S-L: saponins of leaves, ASA: acetylsalicylic acid).
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of observation. Interestingly, the reduction of the edema by 75%
and 90% after administration of TOF-RB and S-RB, respectively,
was highest at 3 h, whereas at the same time, TOF-L and S-L
inhibited the edema by 47% and 65%, respectively. At any rate,
these results indicate that the anti-inflammatory effect may be
related, at least in part, to the presence of flavonoids and saponins.
There have been previous reports on the anti-inflammatory acti-
vity of these types of compounds, including several on their
possible mechanism of action. In general, flavonoids act as po-
tential inhibitors of cyclooxygenase, lipoxygenase, and nitric
oxide synthase as well as being antioxidants (Rao et al., 2005;
Rotelli et al., 2003; Havsteen, 2002;Middleton and Kandaswami,
1992; Middleton et al., 2000; Di Carlo et al., 1999). In contrast,
saponin mechanisms are related to those of steroids, the release of
different enzymes, and the arachidonic acid metabolism (Ríos
et al., 2000; Safayhi and Sailer, 1997).
In the DTH test, examination of challenged ears showed that
oxazolone induced a pronounced inflammatory reaction com-
pared to ears that had not been challenged. Of the extracts as-
sayed, the activity of the ME-RB extract was higher than that of
ME-L, although both extracts significantly reduced ear swelling
(Table 2). Indeed, the ME-RB extract reduced the edema in all
phases of the process by 58%, 36%, and 47% at 24, 48, and 72 h
after challenge, respectively, whereas ME-L only reduced the
edema by 48% and 35% at 24 and 72 h, respectively. It is worth
noting that in this test, only corticosteroids are active because
specific inhibitors of the arachidonic acid metabolism have no
effect on the inflammatory reaction (Cavey et al., 1990; Zunic
et al., 1998; Meurer et al., 1988). These findings suggest that the
mechanism of action of Z. lotus saponins may be related to a
corticosteroid mechanism.
NO plays an important role in diverse physiological processes
including the immune response and inflammation (Ashok et al.,
1999). For this reason, numerous plants have been investigated as
inhibitors of NO production in inflammatory reactions (Lee et al.,
2005; Escandell et al., 2006; Choi et al., 2007). In order to test the
anti-inflammatory activity of Z. lotus extracts, we investigated
their effects on LPS-induced nitrite production in RAW 264.7
macrophages (Table 3). We first tested the cell viability in the
presence of the test extract to determine the toxicity against
murine RAW 264.7 macrophages or rat peritoneal neutrophils
(PMNL). The results showed that at 50 and 100 µg/ml, Z. lotusTable 3
Effects of Z. lotus extracts on nitrite production in RAW 264.7 murine
macrophages (1×106 cells/ml)
Product TOF-L S-L ME-L TOF-RB S-RB ME-RB L-NAME
50 µg/ml (−23) 15 30 (−3) (−67) (−8) –
100 µg/ml 7 50 74 37 14 21 –
1000 µM – – – – – – 105
Nitrite production is assessed as the index of nitric oxide synthase activity.
Values are expressed as inhibition of nitrite production. (TOF-RB: total
oligomers flavonoids of root bark, TOF-L: total oligomers flavonoids of leaves,
S-RB: saponins of root bark, S-L: saponins of leaves, ME-L: methanolic extract
of leaves; ME-RB: methanolic extract of root bark; L-NAME: Nω-nitro-L-
arginine methyl ester was used as reference). Notice: The negative values mean
an increase of nitrite production.extracts were not toxic for cells with viability greater than 95%.
The cytotoxicity was observed at high concentration tested (500
and 1000 µg/ml) with viability percentage 90%. Saponins and
especially the methanolic extract of the leaves (ME-L) signifi-
cantly inhibited nitrite production by 50% and 74%, respectively,
while the TOF-RB and ME-RB extracts of the root bark only had
a moderate effect at 100 μg/ml, whereas at 50 μg/ml both extract
induced the nitrite production, especially S-RB, which would be
of interest for a future research. These results are in contrast with
the in vivo test, in which the extracts obtained from RB were
clearly more active, a fact which suggests that the inhibitors of
nitric oxide synthase are different from the substances responsible
for the anti-inflammatory activity.
In acetic acid-induced writhing in mice, the TOF-RB and S-
L fractions (each at 200 mg/kg) reduced the writhing by 81 and
88%, respectively, whereas TOF-L and S-RB only inhibited the
writhing by 27% and 47%, respectively (Table 4). This type of
writhing in mice has been associated with the liberation of
endogenous substances including serotonin, histamine, prosta-
glandin, and bradykinin (Collier et al., 1968). The results
obtained in this test thus suggest that while Z. lotus extracts
possess peripheral analgesic properties, this particular activity is
probably unrelated to their anti-inflammatory properties.
4. Conclusion
In summary, our results have demonstrated that Z. lotus
exhibits anti-inflammatory activity, inhibits NO production, and
reduces peripheral algesia. These results confirm the potential
interest in Z. lotus as a medicinal plant and open the way for
future research focussing on the active extracts or fractions. Of
special interest are the S-RB fraction as a potential source of anti-
inflammatory principles, theME-RB extract as a possible source
of anti-inflammatory agents in DTH reactions, and the TOF-RB
and S-L fractions as potential sources of analgesic drugs.
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